These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 33157425

  • 1. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
    Xu H, Zhang C, Qian Y, Zou J, Li X, Liu Y, Zhu H, Meng L, Liu S, Zhang W, Yi H, Guan J, Chen Z, Yin S.
    Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of melatonin for sleep disturbance following traumatic brain injury: a randomised controlled trial.
    Grima NA, Rajaratnam SMW, Mansfield D, Sletten TL, Spitz G, Ponsford JL.
    BMC Med; 2018 Jan 19; 16(1):8. PubMed ID: 29347988
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL, Magee M, Murray JM, Gordon CJ, Lovato N, Kennaway DJ, Gwini SM, Bartlett DJ, Lockley SW, Lack LC, Grunstein RR, Rajaratnam SMW, Delayed Sleep on Melatonin (DelSoM) Study Group.
    PLoS Med; 2018 Jun 19; 15(6):e1002587. PubMed ID: 29912983
    [Abstract] [Full Text] [Related]

  • 4. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study.
    Chandra Shekhar H, Joshua L, Thomas JV.
    Adv Ther; 2024 Jan 19; 41(1):246-261. PubMed ID: 37899385
    [Abstract] [Full Text] [Related]

  • 5. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
    Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhães MC, de Lourdes Seabra M, de Bruin VM.
    J Neurol; 2007 Apr 19; 254(4):459-64. PubMed ID: 17404779
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2007 Oct 19; 23(10):2597-605. PubMed ID: 17875243
    [Abstract] [Full Text] [Related]

  • 7. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, Zisapel N.
    BMC Med; 2010 Aug 16; 8():51. PubMed ID: 20712869
    [Abstract] [Full Text] [Related]

  • 8. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A, Schroder CM, Malow BA, Findling RL, Breddy J, Nir T, Shahmoon S, Zisapel N, Gringras P.
    J Child Adolesc Psychopharmacol; 2018 Dec 16; 28(10):699-710. PubMed ID: 30132686
    [Abstract] [Full Text] [Related]

  • 9. A Comparative Study on the Use of Alprazolam and Melatonin for Sleep Disturbances in Hemodialysis Patients.
    Asghar MS, Ahsan MN, Jawed R, Rasheed U, Ali Naqvi SA, Hassan M, Yaseen R, Mallick N, Zehra M, Saleem M.
    Cureus; 2020 Nov 28; 12(11):e11754. PubMed ID: 33403184
    [Abstract] [Full Text] [Related]

  • 10. Effect of melatonin on insomnia and daytime sleepiness, in patients with obstructive sleep apnea and insomnia (COMISA): A randomized double-blinded placebo-controlled trial.
    Motlaq TM, Rahimi B, Amini S.
    J Pharm Health Care Sci; 2024 May 30; 10(1):25. PubMed ID: 38816846
    [Abstract] [Full Text] [Related]

  • 11. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of the melatonin agonist beta-methyl-6-chloromelatonin in primary insomnia: a randomized, placebo-controlled, crossover clinical trial.
    Zemlan FP, Mulchahey JJ, Scharf MB, Mayleben DW, Rosenberg R, Lankford A.
    J Clin Psychiatry; 2005 Mar 07; 66(3):384-90. PubMed ID: 15766306
    [Abstract] [Full Text] [Related]

  • 13. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).
    Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.
    Health Technol Assess; 2012 Mar 07; 16(40):i-239. PubMed ID: 23098680
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
    Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R.
    J Clin Sleep Med; 2010 Dec 15; 6(6):572-80. PubMed ID: 21206546
    [Abstract] [Full Text] [Related]

  • 15. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.
    Curr Med Res Opin; 2011 Jan 15; 27(1):87-98. PubMed ID: 21091391
    [Abstract] [Full Text] [Related]

  • 16. Effect of Transcranial Alternating Current Stimulation for the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial.
    Wang HX, Wang L, Zhang WR, Xue Q, Peng M, Sun ZC, Li LP, Wang K, Yang XT, Jia Y, Zhou QL, Xu ZX, Li N, Dong K, Zhang Q, Song HQ, Zhan SQ, Min BQ, Fan CQ, Zhou AH, Guo XH, Li HB, Liang LR, Yin L, Si TM, Huang J, Yan TY, Cosci F, Kamiya A, Lu J, Wang YP.
    Psychother Psychosom; 2020 Jan 15; 89(1):38-47. PubMed ID: 31846980
    [Abstract] [Full Text] [Related]

  • 17. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.
    Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA.
    Sleep; 2012 Oct 01; 35(10):1395-402. PubMed ID: 23024438
    [Abstract] [Full Text] [Related]

  • 18. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
    Murphy P, Moline M, Mayleben D, Rosenberg R, Zammit G, Pinner K, Dhadda S, Hong Q, Giorgi L, Satlin A.
    J Clin Sleep Med; 2017 Nov 15; 13(11):1289-1299. PubMed ID: 29065953
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
    Huang Z, Zhan S, Chen C, Zhang R, Zhou Y, He J, Lin Z, Bao C, Zhu S, Zhao J, Zhang S, Jiang Y, Wang Y.
    Sleep; 2024 Feb 08; 47(2):. PubMed ID: 37875349
    [Abstract] [Full Text] [Related]

  • 20. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: assessment in a clinical trial of melatonin replacement.
    Hughes RJ, Sack RL, Lewy AJ.
    Sleep; 1998 Feb 08; 21(1):52-68. PubMed ID: 9485533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.